Editorial Policies

Aims and Scope

"Transactional Analysis in Russia" journal is the first Russian-language electronic peer-reviewed journal dedicated to Transactional Analysis - TA (in psychology, psychotherapy, education and organizational fields).

The journal's mission is to promote TA research to expand science-based approaches to therapy, as well as to create an information platform for exchange of opinions in the professional community.

The materials of the journal are addressed to a wide range of professionals in the field of mental health and related disciplines, including opinion leaders of the professional community, scientists, employees of research centers, teachers, doctoral students, postgraduates, university students and practitioners.

The journal covers a wide range of issues in contemporary TA, including its application in clinical psychotherapy and counseling psychology, education, organizations and coaching, basic and interdisciplinary research. It will also publish case studies, supervisions, journalistic materials, event reports and announcements, interviews, exam preparation tips and materials for personal growth.

  • The journal publishes manuscripts under the following headings of the VAK list:
    01.14.06 - Psychiatry (medical sciences);
    01.14.27 - Narcology (medical sciences);
    19.00.04 - Medical psychology (medical sciences, psychological sciences).


Peer Review Process

All scientific articles submitted to the editorial board of the journal "Transactional Analysis in Russia" undergo a mandatory double-blind peer review (the reviewer does not know the authors of the manuscript, the authors of the manuscript do not know the reviewers).

  1. Articles are reviewed by members of the editorial board as well as by invited reviewers - leading experts in the relevant industry who have no scientific, financial or any other relationship with the authors of the article and the editorial board. The decision to choose one or another reviewer for the examination of the article is made by the Editor-in-Chief after the initial review of the article. The period of reviewing is 2-4 weeks. It can be extended at the request of the reviewer.
  2. The review procedure is confidential. Reviewers are notified that the manuscripts sent to them are the intellectual property of the authors and belong to the information that is not subject to disclosure. Reviewers are not allowed to make copies of the manuscript for their own use. Violation of confidentiality is possible only in case of claiming unreliability or falsification of materials. The author of the reviewed work is given the opportunity to read the text of the review.
  3. Each reviewer has the right to refuse a review if there is a clear conflict of interest affecting the perception and interpretation of the manuscript materials.
  4. After reviewing the manuscript, the reviewer makes recommendations about the further treatment of the article (each reviewer's decision is substantiated):
    1. the article is recommended for publication in its present form;
    2. the article is recommended for publication after correction of deficiencies noted by the reviewer;
    3. the article needs additional reviewing by another specialist;
    4. the article cannot be published in the journal.
  5. If the review contains recommendations to correct and improve the article, the editorial board sends the text of the review to the author with a proposal to consider them in the preparation of a new version of the article or to refute them reasonably (partially or completely). Revision of the article should not take more than 1 month from the moment of sending an e-mail with recommendations to the authors. The article finalized by the author should be re-submitted for reviewing.
  6. In case the authors refuse to revise the materials, they should notify the editorial board about their refusal to publish the article in writing or verbally. If the authors do not return the finalized version after 1 month from the date of sending the review, even if there is no feedback from the authors, the editorial board removes it from the register. In such situations, the authors are sent a corresponding notification about deregistration of the manuscript due to the expiry of the period given for revision.
  7. If the author and reviewers have unsolvable contradictions concerning the manuscript, the Editorial Board has the right to send the manuscript for additional reviewing. In controversial situations the decision is made by the Editor-in-Chief at the meeting of the Editorial Board.
  8. The decision to refuse to publish a manuscript is made by the Editor-in-Chief in accordance with the reviewers' recommendations. An article not recommended for publication is not accepted for reconsideration. A message about the refusal to publish and a copy of the review are sent to the author by e-mail.
  9. After the Editor-in-Chief makes a decision on the admission of the article for publication, the editorial board informs the author about this and indicates the date of publication.
  10. Positive review is not a sufficient basis for the publication of the article. The final decision on the publication is made by the Editor-in-Chief. In conflicting situations the decision is made by the Editorial Board.
  11. Articles not accepted for publication:
  • articles not designed in accordance with the requirements for publication, from authors who refuse technical revision of the article.
  • articles, the authors of which do not fulfill the reviewer's constructive comments or do not refute them with arguments. 
  1. The Editorial Board sends copies of reviews to the Ministry of Science and Higher Education of the Russian Federation when a corresponding request is received.
  2. The original reviews are stored in the editorial board for 5 years.

All publicist articles after approval by the Editor-in-Chief are sent to the Editorial Board for revision and design. The author receives an e-mail about the acceptance of the article.


Publication Frequency

The journal is published 3 times a year.


Open Access Policy

Статьи этого журнала доступны всем желающим с момента публикации, что обеспечивает свободный открытый доступ к результатам исследований и способствует прогрессу науки и медицины.



The journal uses the PKP Preservation Network (PKP PN) to digitally preserve all the published articles. The PKP PN is a part of LOCKSS (Lots of Copies Keep Stuff Safe) program offers decentralized and distributed preservation, seamless perpetual access, and preservation of the authentic original version of the content.

Also, the journal makes full-text archives on the Russian Science Electronic Library (http://elibrary.ru/) platform.



  • CrossRef
  • Google Schoolar
  • WorldCat


Publishing Ethics

The Editorial Board of the journal «Transactional Analysis in Russia» ensures the maintenance of ethical principles listed below.

1. Duties of Publisher

1.1. Publisher has a supporting, investing and nurturing role in the scholarly communication process but is also ultimately responsible for ensuring that best practice is followed in its publications. 

1.2 Publisher takes its duties of guardianship over the scholarly record extremely seriously. 

1.3 Publisher should support the journal’s editorial board in consideration of claims to ethic aspects of publishing materials and help to interact with other journals and/or publishers, if it is a responsibility of the editors. 

1.4 Publisher should achieve well-timed publication of journal.

2. Duties of Editors

2.1 The editors of the journal are responsible for deciding which of the articles submitted to the journal should be published. In evaluating the submitted works, the editors should limit themselves only to the intellectual content. The editor may be guided by the policies of the journal's editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism. The editor may confer with other editors or reviewers in making this decision. The editors must ensure the confidentiality of the submitted works until they are published, except in the case of suspicion of double submission. In case the editors decide not to publish a material, the manuscript should not be used for other purposes without the express written consent of the author. The editor of a submitted manuscript must not have a stake in the authors. 

2.2 The editor and any editorial staff must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate. Unpublished materials disclosed in a submitted manuscript must not be used in an editor's own research without the express written consent of the author..

3.    Duties of Reviewers

3.1.Contribution to Editorial Decisions – Peer review assists the editor in making editorial decisions and through the editorial communications with the author may also assist the author in improving the paper. Peer review is an essential component of formal scholarly communication, and lies at the heart of the scientific method. Publisher shares the view of many that all scholars who wish to contribute to publications have an obligation to do a fair share of reviewing. 

3.2.Promptness – Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor of the journal and excuse himself from the review process. 

3.3.Confidentiality – Any manuscripts received for review must be treated as confidential documents. They must not be shown to or discussed with others except as authorised by the editor. 

3.4.Standard and objectivity – Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments. 

3.5.Acknowledgement of Sources – Reviewers should identify relevant published work that has not been cited by the authors. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation. A reviewer should also call to the editor’s attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge. 

3.6.Reviewers have no right to use unpublished manuscript materials in their own research without the express written consent of the author. The reviewer is obliged to refrain from examining the manuscript, in connection with which he has a conflict of interests because of the competitive, cooperative or other relationship with the author or organization related to the manuscript.

4. Duties of Authors

4.1.Reporting standards 4.1.1. Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behavior and are unacceptable. 

4.1.2. Review and professional publication articles should also be accurate and objective, and editorial 'opinion’ works should be clearly identified as such. 

4.2.Data Access and Retention – Authors may be asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data (consistent with the ALPSP-STM Statement on Data and Databases), if practicable, and should in any event be prepared to retain such data for a reasonable time after publication. 

4.3.Originality and Plagiarism 

4.3.1. The authors should ensure that they have written entirely original works, and if the authors have used the work and/or words of others, this has been appropriately cited or quoted. 

4.3.2. Plagiarism takes many forms, from ‘passing off’ another’s paper as the author’s own paper, to copying or paraphrasing substantial parts of another’s paper (without attribution), to claiming results from research conducted by others. Plagiarism in all its forms constitutes unethical publishing behavior and is unacceptable. 

4.4.Multiple, Redundant or Concurrent Publication 

4.4.1. An author should not in general publish manuscripts describing essentially the same research in more than one journal of primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behavior and is unacceptable. 

4.4.2. In general, an author should not submit for consideration in another journal a previously published paper. 

4.4.3. Publication of some kinds of articles (eg, clinical guidelines, translations) in more than one journal is sometimes justifiable, provided certain conditions are met. The authors and editors of the journals concerned must agree to the secondary publication, which must reflect the same data and interpretation of the primary document. The primary reference must be cited in the secondary publication. Further detail on acceptable forms of secondary publication can be found at www.icmje.org. 

4.5.Acknowledgement of Sources – Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work. Information obtained privately, as in conversation, correspondence, or discussion with third parties, must not be used or reported without explicit, written permission from the source. Information obtained in the course of confidential services, such as refereeing manuscripts or grant applications, must not be used without the explicit written permission of the author of the work involved in these services. 

4.6.Authorship of the Paper 

4.6.1. Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors. 

4.6.2. The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper, and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication. 

4.7.Hazards and Human or Animal Subjects 

4.7.1. If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript. 

4.7.2. If the work involves the use of animal or human subjects, the author should ensure that the manuscript contains a statement that all procedures were performed in compliance with relevant laws and institutional guidelines and that the appropriate institutional committee(s) have approved them. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed. All investigations involving humans should be performed in accordance with the principles of Declaration of Helsinki and other WMA documents as updated at their website: https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/ 

4.8.Authors must disclose conflicts of interests that could affect the evaluation and interpretation of their manuscript, as well as the sources of financial support for the project (grants, state programs, projects, etc.), which should be necessarily indicated in the manuscript.

5. Complaints to be handled by the Editorial Board

5.1 Authorship complaints It is important that every author of a contribution be credited as such. It is equally as important that a person not be named as an author when he or she is not. The preference is for authors to resolve such matters amongst themselves, although that is not always possible. 

5.2 Plagiarism complaints Plagiarism is committed when one author uses another work (typically the work of another author) without permission, credit, or acknowledgment. 

5.3 Multiple, duplicate, concurrent publication/Simultaneous submission Articles submitted for publication must be original and must not have been submitted to any other publication. Except in very unusual circumstances (and then only with your agreement as the editor), authors are expected to submit articles that are original and have not been submitted to any other publication. 

5.4 Research results misappropriation Authorship of research results is generally a verifiable question of fact. If there is any question as to whether research results reported in a submitted article are original to the purported author or authors, inquiries of the authors and/or their institutions are made. 

5.5 Allegations of research errors and fraud where referees or readers come to the publisher or editor saying that: certain laboratories do not have the facilities to conduct the research they published; the gel images look manipulated; the data from the control experiments is too perfect etc, then the possibility of fraud needs to be considered. Fraud is publishing data or conclusions that were not generated by experiments or observations, but by data manipulation or invention. Changing the data measurements to conveniently fit the desired end result is fraud, but excluding inconvenient results is deliberate research error, which, in effect, is the same end result – fraud. 

5.6 Research standards violations Research standards violations normally come to light when a referee sees that there was no informed consent on human subjects, or that the animal protection protocols were not being followed. 

5.7 Undisclosed conflicts of interest Public trust in the peer review process and the credibility of published articles depend in part on how well conflict of interest is handled during writing, peer review, and editorial decision making. Conflict of interest exists when an author (or the author’s institution), reviewer, or editor has financial or personal relationships that inappropriately influence (bias) his or her actions (such relationships are also known as dual commitments, competing interests, or competing loyalties).

5.8 With respect to the materials considered for publication editorial board selects independent reviewers having enough experience and no conflict of interests. 

5.9 Reviewer bias or competitive harmful acts by reviewers Editors should avoid selecting external peer reviewers with obvious potential conflicts of interest, for example, those who work in the same department or institution as any of the authors. Authors often provide editors with the names of persons they feel should not be asked to review a manuscript because of potential conflicts of interest, usually professional. When possible, authors should be asked to explain or justify their concerns; that information is important to editors in deciding whether to honour such requests.


Publication Fee

Publication in “Transactional Analysis in Russia is free of charge for all the authors.

The journal doesn't have any Arcticle processing charges.


Adverticement and reprint policy

Our advertising policy is consistent with the principles mentioned in the Recommendations on Publication Ethics Policies for Medical Journals which issued by the World Association of Medical Editors (WAME).


  1. Publisher generate revenue from advertising, which creates a potential conflict of interest. Editors’ decisions do not depend on the cost of advertising or producing reprints. Advertisers and sponsors have no influence over the editor’s decisions, regardless of the terms of advertising or other agreements.
  2. All advertisements are subject to the approval of the Publisher staff, which reserves the right to reject or cancel any advertisement at any time.
  3. The functions of editors and advertising managers in Publisher are separate.
  4. In Publisher professional (physician-directed) publications and web sites, the intentional placement of advertising adjacent to articles discussing the company or product that is the subject of the advertisement is prohibited. Advertising content must be distinguished from editorial and other materials so that the difference between them is obvious.
  5. Publisher will not publish “advertorial” content, and sponsored supplements must be clearly indicated as such. If a supplement did not undergo peer review or underwent a peer review-process different from the rest of the journal that should be explicitly stated.
  6. Editorial Board of Journal have the right to refuse any advertisement that, in its sole discretion, is incompatible with its mission or inconsistent with the values of members, the publication/web site or the organization as a whole, and to stop accepting any advertisement previously accepted. Advertisements are subject to review by the editors and others at the Publisher. In no case shall separate agreements with Publisher or its subsidiaries supersede this policy.
  7. Once an advertisement has been deployed online, it will be withdrawn from the journal site at any time if the Editor(s)-in-Chief or Publisher staff request its removal.
  8. Advertising for the following categories is prohibited:
    • Alcohol
    • Tobacco
    • Weapons, firearms, ammunition
    • Fireworks
    • Gambling and lottery
    • Pornography or related themes
    • Political and religious advertisements
    • Advertisements that claim to have a “miracle” cure or method
    • Advertisements that make unsubstantiated health claims for the products advertised
    • Advertisements directed at children
  9. Advertisements may not be deceptive or misleading, and must be verifiable. Advertisements should clearly identify the advertiser and the product or service being offered. Exaggerated or extravagantly worded copy will not be allowed. Advertisements will not be accepted if they appear to be indecent or offensive in either text or artwork, or if they relate to content of a personal, racial, ethnic, sexual orientation, or religious nature.
  10. All advertisements are accepted and published by Publisher on the warranty of the advertisement agency and advertiser that both are authorized to publish the entire contents and subject matter of the advertisement.
  11. In consideration of publication of an advertisement, the advertiser and the advertisement agency, jointly and severally, agree to indemnify and hold harmless Publisher, its officers, agents and employees against expenses (including legal fees) and losses resulting from the publication of the contents of the advertisement, including, without limitation, claims or suits for libel, violation of privacy, copyright infringement, or plagiarism.
  12. Any references to Publisher or its products or services in advertisements, promotional material, or merchandising by the advertiser or agency is subject to Publisher’s written approval for such use.
  13. All advertisements for drug-specific campaigns must comply with the relevant Russian legislation that regulates advertising. Advertisers should make available to Publisher the marketing authorization and summary of product characteristics when submitting their advertisement. In the case of drug advertisements, proprietary names of pharmaceutical products must be accompanied by the chemical, generic, or official name; the quantity of all active substances must be stated along with the recommended dosage. Each page of an advertisement for a prescription-only medicine should be clearly labeled as intended for health professionals.
  14. Advertisements for products not approved by the FDA or the Ministry of Health of Russian Federation that make any kind of health claims must carry the following disclaimer: “These statements have not been evaluated by the Food and Drug Administration and/or the Ministry of Health of Russian Federation. This product is not intended to diagnose, treat, cure or prevent any disease.”
  15. While Publisher welcomes and encourages information-rich advertising, advertisements, advertising icons and advertiser logos must be clearly distinguishable from editorial content and may require special labeling to distinguish them as such. All advertisements must clearly and prominently identify the advertiser by trademark or signature.
  16. Reprints should be published only in the form in which they were originally published in the journal (including subsequent corrections), so there should be no additions or changes in them.
  17. Publisher is not responsible for incidental or consequential damage for errors in displaying or printing an advertisement.
  18. Advertisements may not imply endorsement by the Publisher or its publications/web sites except as may be provided for under a separate agreement — in which case advertising must be pre-approved to ensure adherence to the letter and spirit of that separate agreement.
  19. The full rules for any market research or promotion associated with an advertisement must be displayed in the advertisement or available via a prominent link.
  20. The following online advertising formats are prohibited:
    • Pop-ups and floating advertisements.
    • Advertisements that collect personally identifiable information from visitors without their knowledge or permission.
    • Advertisements that extend across or down the page without the visitor having clicked or rolled-over the advertisement.
    • Advertisements that send visitors to another site without the visitor having clicked the advertisement.

Publisher published advertising policies are not exhaustive and are subject to change at any time without notice.

We partner with third-party advertising companies to serve ads and/or collect certain information when you visit our website. These companies may use cookies or web beacons to collect non-personally identifiable information [not including your name, address, email address or telephone number] during your visit to this website to help show advertisements on other websites also likely to be of interest to you.

For contact with the Advertisement department of the Publisher, please, follow the link https://consilium.orscience.ru/2075-1753/about/contact 

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies